Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA (Drs Do, Miller, Leonard, Datoc, Girsen, Gibbs, and Aziz); Maternal Fetal Medicine Associates, New York, NY (Dr Do).
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA (Drs Do, Miller, Leonard, Datoc, Girsen, Gibbs, and Aziz).
Am J Obstet Gynecol MFM. 2021 Jul;3(4):100367. doi: 10.1016/j.ajogmf.2021.100367. Epub 2021 Apr 5.
Pregnant women are vulnerable to infection as their immune response is modulated.
Serum biomarkers are used to diagnose and manage severe infections, but data on their utility during labor are limited. We compared lactate and procalcitonin levels in women with and without an intraamniotic infection to determine whether they are useful biomarkers for infection during labor.
We performed a prospective, observational cohort study of term, singleton pregnancies admitted with planned vaginal delivery in 2019 at a university medical center. The lactate and procalcitonin levels were determined during early labor, within 2 hours following delivery, and on postpartum day 1. Women with an intraamniotic infection in addition had their lactate and procalcitonin levels determined following an intraamniotic infection diagnosis. Samples were processed immediately in the hospital clinical laboratory. The primary outcome was the mean lactate level following delivery. The secondary outcomes were the lactate and procalcitonin levels at other time points. Comparisons based on infection status were performed using multivariate linear regressions.
A total of 22 women with intraamniotic infection and 29 uninfected women were included. The mean early labor lactate level (1.47 vs 1.49 mmol/L) and mean procalcitonin level (0.048 vs 0.039 ng/mL) did not differ and were normal in the uninfected and intraamniotic infection groups. The mean lactate level was highest following delivery for women in both the uninfected and intraamniotic infection groups (2.00 vs 2.33 mmol/L; adjusted P=.08; 95% confidence interval, 0.98-1.53). The lactate level returned to normal by postpartum day 1 and did not differ significantly based on the infection status at any time point in the adjusted models. The procalcitonin level following delivery was higher among women with vs without an intraamniotic infection (0.142 vs 0.091 ng/mL; adjusted P=.03). The procalcitonin level rose further in both the intraamniotic infection and uninfected groups on postpartum day 1 (0.737 vs 0.408 ng/mL; adjusted P=.05).
The lactate level is not significantly elevated in pregnant women with an intraamniotic infection above the physiological increase that is observed in women without infection at delivery. The procalcitonin level is elevated at delivery in women with an intraamniotic infection and warrants further investigation as a peripartum infection marker.
孕妇的免疫反应受到调节,因此易感染。
血清生物标志物可用于诊断和治疗严重感染,但关于其在分娩期间应用的数据有限。我们比较了有和无羊膜内感染的孕妇的乳酸和降钙素原水平,以确定它们是否是分娩期间感染的有用生物标志物。
我们进行了一项前瞻性、观察性队列研究,纳入了 2019 年在一所大学医学中心计划经阴道分娩的足月、单胎妊娠孕妇。在早期分娩、分娩后 2 小时内和产后第 1 天测定乳酸和降钙素原水平。此外,有羊膜内感染的孕妇在羊膜内感染诊断后也测定了乳酸和降钙素原水平。标本在医院临床实验室立即处理。主要结局是分娩后平均乳酸水平。次要结局是其他时间点的乳酸和降钙素原水平。基于感染状态的比较采用多元线性回归分析。
共纳入 22 例有羊膜内感染的孕妇和 29 例无感染的孕妇。无感染和羊膜内感染组的早期分娩乳酸水平(1.47 比 1.49 mmol/L)和降钙素原水平(0.048 比 0.039 ng/mL)无差异且均正常。两组孕妇分娩后乳酸水平均最高(2.00 比 2.33 mmol/L;调整后 P=.08;95%置信区间,0.98-1.53)。分娩后乳酸水平在产后第 1 天恢复正常,在调整模型中,任何时间点均无显著差异。与无羊膜内感染相比,羊膜内感染组产妇分娩后降钙素原水平更高(0.142 比 0.091 ng/mL;调整后 P=.03)。产后第 1 天,羊膜内感染组和无感染组降钙素原水平进一步升高(0.737 比 0.408 ng/mL;调整后 P=.05)。
与无感染分娩的孕妇相比,羊膜内感染孕妇的乳酸水平升高并不显著,超过了无感染分娩孕妇的生理性升高。分娩时羊膜内感染孕妇降钙素原水平升高,需要进一步研究作为围产期感染标志物。